123 filings
Page 2 of 7
8-K
8y2h3vs1
22 Apr 22
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
8:47am
8-K
42wivqii36 ck
1 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
uybykb
10 Mar 22
Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financial Results
4:12pm
8-K
0jwj2j hzprvvfioel
13 Jan 22
Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC
4:05pm
8-K
rgp3d9kavfz
19 Nov 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:17pm
8-K
jdjgb yx25
16 Sep 21
Other Events
4:26pm
8-K
pmf23oy024dgyt5k
20 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
fi5 j1q3qued
5 Aug 21
Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
4:13pm
8-K
h91tj2mkrvi6 wwu
2 Jul 21
Other Events
5:07pm
8-K
j8szo9fhfau
1 Jul 21
Other Events
5:18pm
8-K
5vldpckqwp3m2e
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
it0msjunk 3fhxc1
20 May 21
Other Events
7:57am
8-K
oeesn8ky 2fyfx5j4
12 May 21
Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights
4:03pm
8-K
njqymbolslenpk8y
8 Mar 21
Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
4:30pm
8-K
21msxehw m2tcd
3 Mar 21
Salarius Announces Proposed Public Offering of Common Stock
4:23pm
8-K
thjmp
17 Feb 21
Other Events
4:00pm
8-K
3h1buddste2avhu
5 Feb 21
Entry into a Material Definitive Agreement
4:41pm
8-K
h5ylc3lnb5g3sa
21 Jan 21
Other Events
8:00am
8-K/A
pmmytw3
11 Dec 20
Financial Statements and Exhibits
5:01pm
8-K
plswp
11 Dec 20
Entry into a Material Definitive Agreement
8:28am